SCHEMBL25635987

SCHEMBL25635987

O=c1c2ccccc2oc2c(-c3ccccc3)cc(Cl)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 3/20 0.53
▸ ADORA3 P0DMS8 4/20 0.51
▸ CYP3A4 P08684 3/20 0.49
▸ MAOA P21397 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ GLA P06280 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ PGAM1 P18669 1/20 0.49
▸ CASP1 P29466 1/20 0.49
▸ CASP7 P55210 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ CA1 P00915 6/20 0.48
▸ CA2 P00918 6/20 0.48
▸ TNKS O95271 2/20 0.44
▸ CA12 O43570 2/20 0.44
▸ TP53 P04637 2/20 0.44
▸ ABCB1 P08183 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29993340 0.88 AHR (0.51) ADORA3CYP3A4HPGDSMN1; SMN2MAPT
SCHEMBL22884595 0.88 AHR (0.51) ADORA3CYP3A4HPGDSMN1; SMN2MAPT
SCHEMBL25762962 0.85 AHR (0.49) ADORA3CYP3A4HPGDSMN1; SMN2MAPT
SCHEMBL21467883 0.82 MAOA (0.49) TTRADORA3CYP3A4MAOAKDM4E
SCHEMBL5346099 0.81 TTR (0.67) TTRADORA3CYP3A4MAOAKDM4E
SCHEMBL31174010 0.81 TTR (0.67) TTRADORA3CYP3A4MAOAKDM4E
SCHEMBL24171352 0.81 ALOX5 (0.46) ADORA3CA1CA2TNKSGABRP
SCHEMBL25762968 0.81 AHR (0.47) ADORA3CYP3A4HPGDSMN1; SMN2MAPT
SCHEMBL16477273 0.80 MAOA (0.60) TTRADORA3CYP3A4MAOAKDM4E
SCHEMBL25762948 0.79 ALOX5 (0.47) ADORA3CYP3A4HPGDSMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189639-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189639-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF ETV6, OR51E2, NFE2L2 TTR 610/4885ADORA3 4729/4885CYP3A4 1574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback